Retatrutide appears to be a new medication in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, exhibits promising results in clinical trials. By activating these https://zubaireuti193798.blogerus.com/58206464/retatrutide-a-promising-new-treatment-for-obesity